Last reviewed · How we verify

NCT04457128

Real-time Behavioral Interventions

Status unknown NA Last updated 9 November 2020
What this trial tests

NA trial testing Just-in-Time Adaptive Intervention in Cancer in 200 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
30 June 2021
31 August 2021

Quick facts

Lead sponsorUniversity of Alabama, Tuscaloosa
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposeprevention
Enrollment200
Start date1 January 2021
Primary completion30 June 2021
Estimated completion31 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama, Tuscaloosa

Who can join

Adults 50 to 75, any sex, with Cancer or Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to adapt an evidence-based sedentary behavior reduction intervention for men and women living in Alabama and determine its feasibility, acceptance, and limited efficacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Alabama, Tuscaloosa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing